|
Advion developed its Dose Formulation Analysis offering in response to repeated customer requests. After a successful pilot study for a major pharmaceutical company, Advion launched these services in 2006.
Led by our respected scientists, Advion is providing dose formulation analysis in support of preclinical GLP studies. As is the case for all Advion service offerings, Advion's leadership and experience with analytical methods, GLP studies, and sample handling was leveraged and adapted for this service. Advion has talented scientists and uses state-of-the-art LC/UV instrumentation to analyze samples under GLP and other regulatory requirements. Capabilities include LC/UV method development, validation, and sample analysis for:
- Dose Formulation Samples
- End of Study Potency Samples
- hERG Samples
Understanding the needs of its clients, Advion offers this service with rapid turnaround. Preliminary data is delivered within 24-48 hours after receipt of samples. In addition, Advion will lead Dose Formulation Stability and Homogeneity Studies.
If interested in receiving more information about
Advion's Dose Formulation Analysis service, contact CROinfo@advion.com.
Click
here for a copy of our Dose Formulation Analysis overview sheet.
|
